Abstract
Extremely drug-resistant (XDR) Acinetobacter baumannii causes challenging nosocomial infections. We report the case of a patient with XDR A. baumannii pneumonia and septic shock successfully treated with cefiderocol and a novel antibiotic obtained via expanded access protocol. With focused research and drug development efforts, the poor outcomes associated with these infections may be mitigated.
Original language | English (US) |
---|---|
Article number | e00924-21 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 65 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2021 |
Keywords
- Acinetobacter baumanii
- Antibiotic resistance
- Antimicrobial agents
- Beta-lactamases
- Beta-lactams
- Durlobactam
- Gram-negative bacteria
- Gram-negative resistance
- Nosocomial infections
- Novel antibiotics
- Sulbactam-durlobactam
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases